NEUROSENSE THERAPEUTICS LTD (NRSN)
IL0011809592 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.64M | 3.54M | 11.06M | 700.00K | 900.00K | |||
| Marketable Securities | 0.00 | 3.55M | N/A | N/A | N/A | |||
| Receivables | 166.00K | 130.00K | 180.00K | 30.00K | 20.00K | |||
| Other Current Assets | 110.00K | 160.00K | 170.00K | N/A | N/A | |||
| Total Current Assets | 2.92M | 7.38M | 11.41M | 730.00K | 910.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 238.00K | 310.00K | 20.00K | 10.00K | 10.00K | |||
| Other Non-Current Assets | 22.00K | 20.00K | N/A | 40.00K | 40.00K | |||
| Total Non-Current Assets | 260.00K | 330.00K | 20.00K | 50.00K | 50.00K | |||
| TOTAL ASSETS | 3.18M | 7.71M | 11.43M | 780.00K | 960.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 69.00K | 60.00K | N/A | N/A | N/A | |||
| Accrued Expenses | 1.93M | 1.16M | 560.00K | 70.00K | 10.00K | |||
| Accounts Payable | 1.46M | 500.00K | 40.00K | 60.00K | 20.00K | |||
| Total Current Liabilities | 3.46M | 1.73M | 600.00K | 120.00K | 40.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 73.00K | 150.00K | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.52M | 220.00K | 1.83M | N/A | N/A | |||
| Total Non-Current Liabilities | 1.59M | 360.00K | 1.83M | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 5.05M | 2.09M | 2.43M | 120.00K | 40.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -32.07M | -20.79M | -8.45M | -4.41M | -1.58M | |||
| Additional Paid In Capital | 30.19M | 26.41M | 17.45M | 5.06M | 2.50M | |||
| Common Shares | 0.00 | 0.00 | N/A | 0.00 | 0.00 | |||
| Shares Outstanding | 15.38M | 11.78M | 10.94M | 11.35M | 11.35M | |||
| Tangible Book Value per Share | -0.12 | 0.48 | 0.82 | 0.06 | 0.08 | |||
| Total Shareholders' Equity | -1.87M | 5.62M | 9.01M | 660.00K | 920.00K | |||
| TOTAL LIABILITIES AND EQUITY | 3.18M | 7.71M | 11.43M | 780.00K | 960.00K | |||
| Statistics | ||||||||
| Debt/Equity | -0.04 | 0.03 | N/A | N/A | N/A | |||
| Current Ratio | 0.84 | 4.27 | 19.02 | 6.08 | 22.75 | |||
| Return On Assets (ROA) | -355.16% | -160.05% | -35.35% | -362.82% | -127.08% | |||
| Return On Equity (ROE) | N/A | -219.57% | -44.84% | -428.79% | -132.61% | |||
All data in USD